BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23625283)

  • 21. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
    Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The underlying pathophysiology association between the Type 2-diabetic and hepatocellular carcinoma.
    Wei H; Wang J; Li W; Ma R; Xu Z; Luo Z; Lu Y; Zhang X; Long X; Pu J; Tang Q
    J Cell Physiol; 2019 Jul; 234(7):10835-10841. PubMed ID: 30585632
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells].
    He JY; Liu QY; Wei L; Liu ZJ; Huang Y; Yu XQ; Li B; Qin Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):1-7. PubMed ID: 29737080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas.
    Cui C; Lu Z; Yang L; Gao Y; Liu W; Gu L; Yang C; Wilson J; Zhang Z; Xing B; Deng D; Sun ZS
    Mol Carcinog; 2016 Jul; 55(7):1163-74. PubMed ID: 26138747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.
    Gentilini D; Scala S; Gaudenzi G; Garagnani P; Capri M; Cescon M; Grazi GL; Bacalini MG; Pisoni S; Dicitore A; Circelli L; Santagata S; Izzo F; Di Blasio AM; Persani L; Franceschi C; Vitale G
    Oncotarget; 2017 Jun; 8(26):41890-41902. PubMed ID: 28514750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells.
    Abeni E; Salvi A; Marchina E; Traversa M; Arici B; De Petro G
    Int J Oncol; 2017 Jul; 51(1):128-144. PubMed ID: 28560380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermethylation of the PZP gene is associated with hepatocellular carcinoma cell proliferation, invasion and migration.
    Wu M; Lan H; Ye Z; Wang Y
    FEBS Open Bio; 2021 Mar; 11(3):826-832. PubMed ID: 33471436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
    Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M
    Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
    Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
    Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets.
    Stefanska B; Cheishvili D; Suderman M; Arakelian A; Huang J; Hallett M; Han ZG; Al-Mahtab M; Akbar SM; Khan WA; Raqib R; Tanvir I; Khan HA; Rabbani SA; Szyf M
    Clin Cancer Res; 2014 Jun; 20(12):3118-32. PubMed ID: 24763612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
    Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients.
    Fan X; Li Y; Yi X; Chen G; Jin S; Dai Y; Cui B; Dai B; Lin H; Zhou D
    Neoplasia; 2020 Nov; 22(11):630-643. PubMed ID: 33059309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
    Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
    PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic transcriptome analysis of hepatocellular carcinoma.
    Yu CB; Zhu LY; Wang YG; Li F; Zhang XY; Dai WJ
    Tumour Biol; 2016 Oct; 37(10):13323-13331. PubMed ID: 27460080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of the expression of Slit/Robo genes and the methylation status of their promoters in the hepatocellular carcinoma cell lines].
    Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):198-202. PubMed ID: 19335983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
    Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.